* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Questions for Term Test #2
Orphan drug wikipedia , lookup
Polysubstance dependence wikipedia , lookup
Cannabinoid receptor antagonist wikipedia , lookup
Psychopharmacology wikipedia , lookup
Compounding wikipedia , lookup
Discovery and development of beta-blockers wikipedia , lookup
Pharmacognosy wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Theralizumab wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Prescription costs wikipedia , lookup
Prescription drug prices in the United States wikipedia , lookup
Drug design wikipedia , lookup
Drug discovery wikipedia , lookup
Drug interaction wikipedia , lookup
Nicotinic agonist wikipedia , lookup
Questions for Term Test #2 1. A 2-selective agonist is administered to a diabetic patient. Is this a good treatment? Explain why / why not? 2. A patient you have been treating for hypertension by prescribing propranolol, a βadrenergic receptor antagonist (β-blocker), suddenly stops taking his medication and develops heart palpitations and rhythm irregularities. What receptor mechanism might explain his current problem? a. Chronic β-blockers caused downregulation of cardiac β-receptors. b. β-Blockers are still in his bloodstream exerting an effect one day after stopping. c. Chronic β-blocker treatment caused supersensitivity of cardiac βreceptors. d. He should have been on another type of antihypertensive medication. e. Over time, β-blocker treatment caused desensitivity of β-receptors. 3. Which one of the following statements best describes drugs classified as partial receptor agonists? a. Partial agonists are prodrugs that split into full agonists in the body b. Full agonists are more potent than partial agonists c. Partial agonists have less efficacy than full agonists d. Partial agonists are also called negative antagonists. e. Competitive antagonists used at low concentrations act like partial agonists. 4. Full and partial agonists are co-administered. The observed effect is: a. tachyphylaxis b. synergism c. competitive inhibition d. pharmacodynamic tolerance e. inverse antagonism 5. Drug A has a therapeutic interval of 10. Drug B has a therapeutic interval of 2. Which is the safest drug? Explain why BRIEFLY. 2 marks 6. Drug A is more potent than drug B. Which of the following are true? a. Drug A has a higher ED50 and a lower Kd than drug B. b. Drug A has a higher ED50 and a higher Kd50 drug B. c. Drug A has a higher efficacy and lower ED50 than drug B. d. Drug A has a lower ED50 and a lower Kd than drug B. e. Drug A has a higher efficacy and a lower Kd than drug B. f. All of the above g. None of the above 7. A drug is known to have a CSF of 42. Given that the ED99 and ED50 are 400 mg, and 275 mg respectively, calculate the dose of drug that is lethal in 1% of the population. 8. Draw Drug concentration vs physiological response curves for the following drugs and the natural ligand (acetylcholine) given the following information: KD Type of agonist Acetylcholine 1 uM full Zx120 5 uM partial (50%) ZQ100 1 uM full WY135 7 uM inverse (-10%) 9. A 48-year-old man is diagnosed with Sjögren's syndrome, which is characterized by chronic dry mouth due to undersecretion of saliva (xerostomia). Which one of the following agents might best treat his condition? a) muscarinic antagonist b) reversible acetylcholinesterase inhibitor c) irreversible acetylcholinesterase inhibitor d) muscarinic agonist e) 1 adrenergic receptor agonist